Compare Uroxatral vs. Hytrin

Head-to-head comparisons of medication uses, side effects, ratings, and more.

ADVERTISEMENT
Makes it easier to urinate.

Uroxatral (alfuzosin) is a good treatment for an enlarged prostate if medical treatment is needed.

No information currently available
Upsides
  • Uroxatral (alfuzosin) works just as well as other similar medications but with fewer/less severe side effects.
  • Available as a generic medication.
  • Simple once daily dosing.
No information currently available
Downsides
  • Uroxatral (alfuzosin) treats the symptoms of an enlarged prostate. It doesn't make the prostate smaller or stop it from getting bigger.
  • Uroxatral (alfuzosin) interacts with many medications. Talk with your doctor or pharmacist before starting any new medication including non-prescription medications, natural products, and vitamins.
  • Uroxatral (alfuzosin) can affect heart rhythms.
No information currently available
ADVERTISEMENT
Used for
  • BPH
  • Promote kidney stone passage
  • Benign prostatic hyperplasia Hypertension
  • Chronic prostatitis - chronic pelvic pain syndrome Hyperlipidemia Nocturia Oligozoospermia Radiation-induced disorder - Urethritis Spinal cord injury
Dosage forms
  • Pill
  • Pill
Price
Want to save even more money?
Sign up now for a 30-day trial and save up to 95% at CVS, Kroger, Albertsons, and other pharmacies.
Learn more
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
4possible side effects
  • Dizziness
    6%
  • Upper lung infection
    3%
  • Headache
    3%
  • Fatigue
    3%
See more detailed side effects
The Hytrin (Terazosin) FDA package insert doesn’t have numbers about how common side effects are.
Risks and risk factors
  • Low blood pressure
    • Taking medications for high blood pressure
  • Drug interactions
    • Taking multiple medications
  • Floppy iris syndrome
    • Cataract or glaucoma surgery
  • Prolonged penile erection
  • Liver impairment
    • Liver impairment
See more detailed risks and warnings
No information currently available